Dr. Collins awarded CIHR Project Grant

Date Posted: 
Dr. Colin Collins

Dr. Colin Collins has been awarded a five-year CIHR Project Grant for "Uncovering early mediators of lineage plasticity and validation of a metabolic vulnerability in neuroendocrine prostate cancer" (co-investigators: Dr. YZ Wang and Dr. Martin Gleave). 

This project will study two potential therapeutic approaches aimed at  preventing the onset of neuroendocrine prostate cancer (NEPC), which currently has no effective therapies for treatment or prevention.  Adenocarcinoma of the prostate ultimately progresses to castrate-resistant prostate cancer, which can become lethal NEPC through the process of neuroendocrine transdifferentiation (NEtD). By testing the effect of blocking pathways supsected to cause NEtD in model systems, the aim is to discover novel therapeutic targets.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.


VPC Terry Fox team 2016

Terry Fox Run - September 20, 2020

The 40th annual Terry Fox Run takes place on Sunday September 20 across Canada, as a virtual event.  Please consider donating to or joining our TFRI-VPC team as we raise funds to enable The Terry Fox Foundation & The Terry Fox Research Institute to continue their support of innovative and progressive cancer research programs


Work at the Vancouver Prostate Centre

Thursday, March 4, 2021

Dr. Collins awarded CIHR Project Grant

Dr. Colin Collins
Friday, January 22, 2021

Dr. Nappi receives MSFHR 2020 Health Professional-Investigator Award